Blood cancers

Vigilance for CMV urged with nivolumab

Patients on the checkpoint inhibitor nivolumab who present with symptoms of colitis should be investigated to exclude other causes, including infections such as cytomegalovirus, a drug safety update advises.  A Europe wide review identified 20 serious cases suggestive of cytomegalovirus (CMV) infection or reactivation with nivolumab monotherapy. A further 8 cases were reported of either ...

Already a member?

Login to keep reading.

© 2021 the limbic